Skip to content

NEKTAR THERAPEUTICS

NKTR

CIK 0000906709

← back to feed
Revenue (TTM)
$44.29M
−43.9% YoY Q1 May 2026
Net Income (TTM)
−$172.9M
−37.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$10.26
−12.1% YoY Q1 May 2026
Gross Margin
1.4%
Q1 May 2026
Operating Margin
-342.1%
Q1 May 2026
Net Margin
-390.4%
Q1 May 2026
Free Cash Flow (TTM)
−$193.76M
Q1 May 2026
Cash
$149.58M
Q1 May 2026
Total Debt
$133.5M
Q1 May 2026
Shares Outstanding
33.79M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings